SEARCH

SEARCH BY CITATION

References

  • Broos, J., ter Veld, F., and Robillard, G.T. 1999. Membrane protein–ligand interactions in Escherichia coli vesicles and living cells monitored via a biosynthetically incorporated tryptophan analogue. Biochemistry 38: 97989803.
  • Broos, J., Gabellieri, E., Biemans-Oldehinkel, E., and Strambini, G.B. 2003. Efficient biosynthetic incorporation of tryptophan and indole analogs in an integral membrane protein. Protein Sci. 12: 19912000.
  • Calandra, B., Tucker, J., Shire, D., and Grisshammer, R. 1997. Expression in Escherichia coli and characterisation of the human central CB1 and peripheral CB2 cannabinoid receptors. Biotechnol. Lett. 19: 425428.
  • Chin, C.N., Murphy, J.W., Huffman, J.W., and Kendall, D.A. 1999. The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor. J. Pharmacol. Exp. Therap. 291: 837844.
  • Felder, C.C., Veluz, J.S., Williams, H.L., Briley, E.M., and Matsuda, L.A. 1992. Cannabinoid agonists stimulate both receptor-mediated and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42: 838845.
  • Felder, C.C., Joyce, K.E., Briley, E.M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A.L., and Mitchell, R.L. 1995. Comparison of the pharmacology and signal-transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 48: 443450.
  • Feng, W., Cai, H., Pierce, W.M., and Song, Z.H. 2002. Expression of CB2 cannabinoid receptor in Pichia pastoris. Prot. Express. Purification 26: 496505.
  • Gaede, H.C., Luckett, K.M., Polozov, I.V., and Gawrisch, K. 2004. Multinuclear NMR studies of single lipid bilayers supported in cylindrical aluminum oxide nanopores. Langmuir 20: 77117719.
  • Glass, M. and Northup, J.K. 1999. Agonist selective regulation of G proteins by cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 56: 13621369.
  • Grisshammer, R. and Tucker, J. 1997. Quantitative evaluation of neurotensin receptor purification by immobilized metal affinity chromatography. Prot. Express. Purification 11: 5360.
  • Grisshammer, R., Averbeck, P., and Sohal, A.K. 1999. Improved purification of a rat neurotensin receptor expressed in Escherichia coli. Biochem. Soc. Trans. 27: 899903.
  • Hwang, T.L. and Shaka, A.J. 1995. Water suppression that works—Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. Series A 112: 275279.
  • Jackson, M.L. and Litman, B.J. 1985. Rhodopsin-egg phosphatidylcholine reconstitution by an octyl glucoside dilution procedure. Biochim. Biophys. Acta 812: 369376.
  • Kapust, R.B., Tozser, J., Fox, J.D., Anderson, D.E., Cherry, S., Copeland, T.D., and Waugh, D.S. 2001. Tobacco etch virus protease: Mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Prot. Engineering 14: 9931000.
  • Lan, R.X., Liu, Q., Fan, P.S., Lin, S.Y., Fernando, S.R., McCallion, D., Pertwee, R., and Makriyannis, A. 1999. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 42: 769776.
  • Martin, B.R. 1986. Cellular effects of cannabinoids. Pharmacol. Rev. 38: 4574.
  • Matsuda, L.A. 1997. Molecular aspects of cannabinoid receptors. Crit. Rev. Neurobiol. 11: 143166.
  • Munro, S., Thomas, K.L., and Abushaar, M. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 6165.
  • Ohguro, H., Rudnicka Nawrot, M., Buczylko, J., Zhao, X.Y., Taylor, J.A., Walsh, K.A., and Palczewski, K. 1996. Structural and enzymatic aspects of rhodopsin phosphorylation. J. Biol. Chem. 271: 52155224.
  • Pertwee, R.G. 1999. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6: 635664.
  • Pertwee, R.G. 2000. Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development. Expert Opin. Invest. Drugs 9: 15531571.
  • Pertwee, R.G. 2001. Cannabinoid receptor ligands. Tocris Rev. 16: 18.
  • Rajesh, S., Nietlispach, D., Nakayama, H., Takio, K., Laue, E.D., Shibata, T., and Ito, Y. 2003. A novel method for the biosynthesis of deuterated proteins with selective protonation at the aromatic rings of Phe, Tyr and Trp. J. Biomol. NMR 27: 8186.
  • Ross, R.A., Brockie, H.C., Stevenson, L.A., Murphy, V.L., Templeton, F., Makriyannis, A., and Pertwee, R.G. 1999. Agonist inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630. Brit. J. Pharmacol. 126: 665672.
  • Sambrook, J. and Russell, D.W. 2001. Molecular cloning: A laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  • Stinson, A.M., Wiegand, R.D., and Anderson, R.E. 1991. Recycling of docosahexaenoic acid in rat retinas during N-3 fatty-acid deficiency. J. Lipid Res. 32: 20092017.
  • Tai, S.P. and Kaplan, S. 1985. Intracellular localization of phospholipid transfer activity in Rhodopseudomonas sphaeroides and a possible role in membrane biogenesis. J. Bacteriol. 164: 181186.
  • Tucker, J. and Grisshammer, R. 1996. Purification of a rat neurotensin receptor expressed in Escherichia coli. Biochem. J. 317: 891899.
  • Weiss, R.L. 1976. Protoplast formation in Escherichia coli. J. Bacteriol. 128: 668670.
  • Weiss, H.M. and Grisshammer, R. 2002. Purification and characterization of the human adenosine A(2a) receptor functionally expressed in Escherichia coli. Eur. J. Biochem. 269: 8292.
  • White, J.F., Trinh, L.B., Shiloach, J., and Grisshammer, R. 2004. Automated large-scale purification of a G protein-coupled receptor for neurotensin. FEBS Lett. 564: 289293.